Member access

4-Traders Homepage  >  Shares  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
10/17/2014 10/20/2014 10/21/2014 10/22/2014 10/23/2014 Date
2735.05(c) 2738(c) 2710(c) 2706(c) 2710 Last
6 487 5 344 4 948 5 294 3 053 Volume
+1.79% +0.11% -1.02% -0.15% +0.15% Change
More quotes
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
11/06Earnings Release
Surperformance© rating of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More about the company
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Financials ( INR)
Sales 2014 27 825 M
EBIT 2014 6 213 M
Net income 2014 5 302 M
Finance 2014 13 510 M
Yield 2014 2,05%
Sales 2015 30 568 M
EBIT 2015 7 279 M
Net income 2015 6 401 M
Finance 2015 9 287 M
Yield 2015 2,13%
PER 2014 43,23
PER 2015 35,88
EV / Sales 2014 7,76x
EV / Sales 2015 7,20x
Capitalization 229 507 M
More Financials
Latest news on GLAXOSMITHKLINE PHARMACEUT
4h ago GLAXOSMITHKLINE : DIRECTOR DEALINGS: Glaxo Chief Executive Exercises Options, Se..
14h ago GLAXOSMITHKLINE PHARMACEUTICALS : Law firms from US boost their HK staffs
1d ago GLAXOSMITHKLINE PHARMACEUTICALS : Law firms from US boost their HK staffs
1d ago GLAXOSMITHKLINE PHARMACEUTICALS : Law firms from US boost their HK staffs
1d ago Glaxo Holds Full Year Expectations, But Launches New Restructuring
6d ago GLAXOSMITHKLINE : PRESS: Glaxo's Ebola Drug To "Come Too Late" For Current Outbr..
6d ago GLAXOSMITHKLINE : Glaxo Gets Positive Results For Anoro Ellipta COPD Treatment
10/15 GLAXOSMITHKLINE PHARMACEUTICALS : Taurus Securities Limited Market Roundup
10/14 GLAXOSMITHKLINE : DIRECTOR DEALINGS: Glaxo Directors, Managers Reinvest Dividend..
10/08 GLAXOSMITHKLINE : PRESS: Glaxo Investigating Allegations In United Arab Emirates..
10/07 GLAXOSMITHKLINE : Glaxo's Stiefel Starts Phase III Study Of Subcutaneous Ofatumu..
10/01 Isis Pharma Earns USD1.5 Million From Glaxo For ISIS-GSK4 Rx
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF